SCHEMBL20346643

SCHEMBL20346643

O=c1c2ccccc2oc2ccc3c(F)cccc3c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 10/20 0.56
HPGD P15428 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
GLA P06280 1/20 0.55
CYP3A4 P08684 1/20 0.55
MAPT P10636 1/20 0.55
PGAM1 P18669 1/20 0.55
CASP1 P29466 1/20 0.55
CASP7 P55210 1/20 0.55
HSD17B10 Q99714 1/20 0.55
NMUR2 Q9GZQ4 1/20 0.49
MGAM O43451 1/20 0.46
GAA P10253 1/20 0.46
SI P14410 1/20 0.46
MGAM2 Q2M2H8 1/20 0.46
KDM5A P29375 1/20 0.45
TTR P02766 2/20 0.43
NPC1 O15118 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9282004 0.86 MAOA (0.63) MAOAHPGDSMN1; SMN2KDM4EALDH1A1
SCHEMBL20346626 0.85 MAOA (0.53) MAOAHPGDSMN1; SMN2KDM4EALDH1A1
SCHEMBL20346638 0.81 MAOA (0.53) MAOAHPGDSMN1; SMN2KDM4EALDH1A1
SCHEMBL20346606 0.80 MAOA (0.75) MAOAHPGDSMN1; SMN2KDM4EALDH1A1
SCHEMBL20346618 0.80 MAOA (0.56) MAOAHPGDSMN1; SMN2KDM4EALDH1A1
SCHEMBL20346625 0.80 MAOA (0.56) MAOAHPGDSMN1; SMN2KDM4EALDH1A1
SCHEMBL20349960 0.80 MAOA (0.51) MAOAHPGDSMN1; SMN2KDM4EALDH1A1
SCHEMBL22128470 0.79 MAOA (0.59) MAOAHPGDSMN1; SMN2KDM4EALDH1A1
Acetic Acid SCHEMBL30589868 0.78 MAOA (0.57) MAOAHPGDSMN1; SMN2KDM4EALDH1A1
SCHEMBL20346634 0.78 MAOA (0.52) MAOAHPGDSMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180185325-A1 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME THESAN PHARMACEUTICALS, INC. (US) 2018-07-05 US disclosed
US-20180185325-A1 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME THESAN PHARMACEUTICALS, INC. (US) 2018-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180185325-A1 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME AHR, NR1H2, NR1H3 MAOA 408/4885HPGD 303/4885SMN1; SMN2 2217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.